SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-127444
Filing Date
2019-04-30
Accepted
2019-04-30 08:29:03
Documents
6
Period of Report
2019-04-26
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d940258d8k.htm 8-K 21292
2 EX-10.1 d940258dex101.htm EX-10.1 25704
3 EX-99.1 d940258dex991.htm EX-99.1 188151
4 GRAPHIC g940258g0426074801070.jpg GRAPHIC 3343
5 GRAPHIC g940258g0426075400310.jpg GRAPHIC 3016
6 GRAPHIC g940258g0430041256878.jpg GRAPHIC 7687
  Complete submission text file 0001193125-19-127444.txt   256453
Mailing Address 3471 RIVER HILLS DRIVE CINCINNATI OH 45244
Business Address 3471 RIVER HILLS DR CINCINNATI OH 45244 5132713700
MERIDIAN BIOSCIENCE INC (Filer) CIK: 0000794172 (see all company filings)

IRS No.: 310888197 | State of Incorp.: OH | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 000-14902 | Film No.: 19778623
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Office of Life Sciences